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Abstract
Purpose: A method for automatically quantifying emphysema regions using
High-Resolution Computed Tomography (HRCT) scans of patients with chronic
obstructive pulmonary disease (COPD) that does not require manually annotated
scans for training is presented.
Methods: HRCT scans of controls and of COPD patients with diverse disease
severity are acquired at two different centers. Textural features from co-occurrence
matrices and Gaussian filter banks are used to characterize the lung parenchyma
in the scans. Two robust versions of multiple instance learning (MIL) classifiers
that can handle weakly labeled data, miSVM and MILES, are investigated. Weak
labels give information relative to the emphysema without indicating the location
of the lesions. The classifiers are trained with the weak labels extracted from the
forced expiratory volume in one minute (FEV1) and diffusing capacity of the lungs
for carbon monoxide (DLCO). At test time, the classifiers output a patient label
indicating overall COPD diagnosis and local labels indicating the presence of
emphysema. The classifier performance is compared with manual annotations
made by two radiologists, a classical density based method, and pulmonary
function tests (PFTs).
Results: The miSVM classifier performed better than MILES on both patient
and emphysema classification. The classifier has a stronger correlation with PFT
than the density based method, the percentage of emphysema in the intersection
of annotations from both radiologists, and the percentage of emphysema
annotated by one of the radiologists. The correlation between the classifier and
the PFT is only outperformed by the second radiologist.
Conclusions: The presented method uses MIL classifiers to automatically
identify emphysema regions in HRCT scans. Furthermore, this approach has been
demonstrated to correlate better with DLCO than a classical density based
method or a radiologist, which is known to be affected in emphysema. Therefore,
it is relevant to facilitate assessment of emphysema and to reduce inter-observer
variability.
Keywords: COPD, multiple instance learning, weakly-supervised learning,
texture analysis, chest HRCT.
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1 Introduction
Chronic obstructive pulmonary disease (COPD) is the most important respiratory
disease worldwide and one of the most important causes of death in high and
middle-income countries [1, 2]. COPD is described as a progressive and irreversible
airflow limitation. Emphysema is one of the most common disease manifestations that
causes this limitation due to the destruction of alveolar walls and loss of elasticity [3].
Emphysema can be identified visually in computed tomography (CT) scans as low
attenuation areas (LAA). However, to enable the detection of lesions smaller than 5 mm,
thin slice reconstructions, such as high-resolution computed tomography (HRCT) scans,
are preferred.
The automatic identification and quantification of emphysema provides objectivity
and more reliability to the clinical routine in the assessment of COPD. Currently,
emphysema is assessed visually, which is time consuming, subjective and suffers from
inter- and intra-observer variability [4]. Over the years, the most used methods for
automatically quantifying emphysema have been density based [5–7]. These methods
use a threshold based on percentile density or LAA, generally lower than -950
Hounsfield units (HU). However, these methods are very dependent on, among others,
the inspiration level, scanner reconstruction kernel, exposure dose and scanners.
Therefore, there is no consensus on the best threshold for quantifying emphysema [8, 9].
Other quantification methods have been reported based on texture features, which
collect information about the spatial relationship of the intensity values in the
scan [10–12]. Machine learning methods based on texture analysis extract information
to learn normal and abnormal lung tissues, which facilitates the recognition of disease
patterns and can therefore lead to a more reliable diagnosis [13]. In general, machine
learning methods use supervised classifiers that require annotated regions of interest
(ROIs) or labeled patches based on manual annotations of emphysema performed by
clinical experts [14–17]. Manual annotations are even more time consuming than visual
assessment of emphysema and also suffer from inter-observer variation [18].
Learning from weak labels, which assign a label to the entire image, is proposed in
the literature as the less time-consuming alternative to the manual annotation of
patches, and it is being increasingly used in different medical image analysis
applications [19–21]. Weak labels are easier to acquire than manual annotations because
they can be obtained from basic quantification methods or complimentary data of the
patient, such as pulmonary function tests (PFTs) or bio-markers. Classifiers which
learn from weak labels are referred to as multiple instance learning (MIL) classifiers. All
MIL classifiers can learn to label entire scans. For example, Sørensen et al. [22] and
Cheplygina et al. [19] used spirometry results, which is the most common PFT to
clinically assess COPD, to assign labels to scans from the Danish Lung Cancer
Screening Trial, and trained different types of MIL classifiers to detect COPD in
previously unseen scans from the same trial. However, a subset of MIL classifiers can
also learn to classify individual patches, thus identifying regions with signs of COPD,
including emphysema. Neither [22] nor [19] evaluated MIL classifiers for this purpose.
For example, more than half of the classifiers studied in [19] including the best
performing classifier, could not provide individual patch labels.
In contrast with previous studies, this study aims to automatically identify
emphysema regions in patients with COPD using HRCT scans without local annotations.
Different texture-based methods and MIL classifiers are investigated. Furthermore, in
this study, more robust versions of two MIL classifiers are proposed. The results from
the classifiers are evaluated with manual annotations made by two radiologists.
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2 Materials and Methods
This study focuses on automatically distinguishing emphysema without using manual
annotations to train the classifiers. For this purpose, different types of texture features
are extracted to characterize emphysema, and two variations of MIL classifiers are
investigated. Fig 1 presents an overview of the method used.
Figure 1. Summary of the methodology. Texture features are extracted from the lung
parenchyma. Two different MIL classifiers are trained and are tested on previously
unseen scans. The results are evaluated against manual annotations performed by two
radiologists, a density based analysis, and pulmonary function tests.
2.1 Features
Two different types of texture features are computed: features from co-occurrence
matrices and Gaussian derivative features. The co-occurrence matrix algorithm is used
in 3D, and it aims to capture the spatial dependence of gray-level intensities through
multiple slices. The co-occurrence of voxel pairs is evaluated in 13 directions and at five
different distances. After obtaining the co-occurrence matrices, the spatial dependencies
of gray-level values are described by 12 Haralick textural features: energy, entropy,
correlation, contrast, homogeneity, variance, sum mean, inverse difference moment,
inertia, cluster shade, cluster tendency and max probability [23].
Gaussian derivative features aim to capture the presence of structures such as edges
and blobs. Each image is first convolved (using normalized convolution) with a
Gaussian function: G(v, σ) = 1
(((2pi)1/2σ)3)
exp (− (||v||22)(2σ2) ), where σ represents the
standard deviation of the Gaussian, or the scale at which the texture is examined, and
v = [x, y, z]T is a voxel. Similar to [22], eight filters are computed: smoothed image,
gradient magnitude, Laplacian of Gaussian, three eigenvalues of the Hessian, Gaussian
curvature, and eigen magnitude. The filters are computed at four different scales:
0.6mm, 1.2mm, 2.4mm, and 4.8mm. The filtered outputs are summarized using
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histograms with ten bins, where the bin sizes are determined by adaptive binning [24]
on an independent dataset [22] prior to this study.
2.2 Classifiers
MIL is originally a binary classification problem, although multi-class extensions also
exist [25]. MIL classifiers are trained on labeled bags {(Bi, yi)|i = 1, ...N}, where i
indicates the i-th out of total N subjects, and yi is the label (yi = +1 for COPD, or
yi = −1 for non-COPD) of the i-th subject. The bags are also referred to as positive or
negative. Each bag Bi = {xij |j = 1, ..., ni} ⊂ Rd, is a set of ni texture feature vectors
or instances, where xij describes the j-th patch of the i-th subject.
In this study, the bags represent the entire scan of an individual subject, whereas the
instances are randomly selected 3D patches from inside the lungs. The bags are related
to the weak labels extracted from the pulmonary function tests, and the instance labels
classify the lung parenchyma into emphysematous or healthy lung tissue. Typically,
MIL classifiers assume that there are instance labels yij that relate to the bag labels as
follows: a bag is positive if and only if it contains at least one positive or concept
instance: yi = maxj yij . Thus, a bag is classified as positive if at least one instance
contains emphysematous tissue. In this study a less strict assumption is used, as
described in Section 2.3.
There are two main strategies that MIL classifiers follow [19,26]. The instance-level
strategy is to use the bag labels to infer an instance classifier. To classify a previously
unseen test bag, such classifiers classify its instances and then combine the instance
labels into a bag label. The bag-level strategy is to represent the bags by some global
characteristics and use supervised classifiers to classify the bags directly. Inferring the
instance labels from the bag labels is not always possible in this case. In this study, the
posterior probability that a classifier outputs for a bag is denoted as f(Bi) and the
posterior probability that a classifier outputs for an instance as f(xij).
Two popular and effective MIL classifiers are miSVM [27] and MILES [28]. The
instance-level miSVM classifier extends the traditional support vector machine (SVM)
by searching for an instance classifier that separates the instances as well as possible but
such that the maxj {yij} = yi condition still holds. In other words, the most positive
(according to the classifier) instance in each bag is positive if the bag is positive and
negative if the bag is negative. Similar to a supervised SVM, the miSVM can operate
on polynomial or radial basis kernels between instances. A regularization parameter C
controls the trade-off between the margin, i.e. how well the instances are separated, and
how many training bags are incorrectly classified with this margin. For a test bag, its
instances are classified, and the most positive instance determines the label of the bag.
MILES is a bag-level approach that is able to infer instance labels. It assumes that
positive and negative bags contain discriminative prototype instances. It represents
each bag by a feature vector si that contains its similarities to all instances in the
training set, where the similarity is defined as s(Bi,x) = maxj k(xij ,x), in which k is a
similarity function between instances, i.e., a polynomial or radial basis kernel. The
maximum operator implies that the bag’s similarity to an instance is high if it contains
a single similar instance. The MILES classifier then selects discriminative similarities,
which correspond to discriminative prototype instances. A regularization parameter C
controls the trade-off between how many bags are incorrectly classified and how many
discriminative prototypes are selected. For a test bag, the similarity to the
discriminative prototypes determine whether the bag is positive (if it has instances
sufficiently similar prototypes from positive bags).
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2.3 Avoiding false positives
Because a single positive instance is sufficient to classify whether a bag is positive,
miSVM and MILES may suffer from false positives. In this study, more robust
formulations of miSVM and MILES are proposed, which we refer to as miSVM-Q and
MILES-Q, which use the quantile rather than the maximum operator to define the label
of the bag. In miSVM-Q, maxj {yij} = yi is replaced by quantilej({yij}, q) = yi, where
q is the desired quantile. For example, if q = 0.5, half of the instances must be positive
for a bag to be positive.
In MILES-Q, the similarity function to s(Bi,x) = quantilej({k(xij ,x)}, q) is
adapted. This means that the bag must contain more similar instances to the prototype
x to be considered similar to it. For both miSVM-Q and MILES-Q, these adaptations
mean that healthy subjects can still be considered healthy if they have a few
emphysematous patches.
Furthermore, this study proposes an additional measure to evaluate a MIL classifier
f , which is called Separability or S:
S =
1∑
yi=+1
ni
∑
yi=+1
f(xij)− 1∑
yi=−1 ni
∑
yi=−1
f(xij). (1)
In other words, the Separability describes the difference between the average
posterior probabilities of instances in true positive training bags, and the average
posterior probabilities of instances in true negative training bags. The intuition behind
this is that true positive bags should have a larger proportion of positive instances, and
therefore the average instance posterior probability should be higher than in negative
bags. This allows reasoning about the classifier’s performance on instance-level, without
having access to instance labels.
Consider two classifiers f1 and f2 which classify a positive and a negative bag, each
with two instances. For the positive bag, f1 outputs posteriors 0.51 and 0.49, and f2
outputs posteriors 0.9 and 0.1. For the negative bag, f1 outputs 0.49 and 0.49, while f2
outputs 0.1 and 0.1. While both f1 and f2 correctly classify the bags, f2 would be the
preferred classifier on instance-level. The Separability of f1 and f2 are respectively 0.01
and 0.4, which reflects our preference for f2. Since Separability is a difference of two
averages, each of which is between 0 and 1, Separability could theoretically range
between -1 and 1. In our experiments we observed that most values fall between 0.05
and 0.75.
3 Experimental
3.1 Data
Two datasets are used in this study. Both datasets are named after the hospital where
the HRCT scans were performed: Frederikshavn (Fre) and Aalborg (Aal). For both
datasets, volumetric (helical) HRCT scans and pulmonary function tests (PFTs) are
performed.
The PFTs are spirometry and diffusing capacity of the lungs for carbon monoxide
(DLCO) and are acquired for each patient. PFTs and HRCT scans are performed with
the patients in a steady state, i.e., no exacerbation within six weeks prior to the test,
and HRCT scans are acquired with the patients in the supine position and with breath
held. No contrast agents are used.
Volumetric (helical) HRCT scans from both datasets are acquired with the patients
in supine position and with breath hold. No contrast agents are used. In the
Frederikshavn dataset, the scans are performed on a Siemens SOMATOM Definition
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Flash CT scanner with scan parameters as follows: 0.6 slice thickness, 95 mAs, 120 kvp,
rotation time 0.5 seconds, CTDIvol 7.96 mGy, pitch 1.2 with a image voxel resolution of
0.58×0.588×0.6 mm. In the Aalborg dataset, the scans are achieved using a GE 160
Discovery CT750 HD scanner with with scan parameters as follows: 0.625 slice
thickness, 120 kvp, rotation time 0.5 seconds, CTDIvol 5.12 mGy, pitch 0.984,
automatically calculated mA by GE´s Smart mA system (max 300 mA and Noise Index
40) and image voxel resolution of 0.788×0.788×0.6 mm.
Note that the dose is higher for the Siemens scan than for the GE scan, however the
scans were visually inspected by the two radiologists who performed the clinical
validation and they concluded that the visual quality of the scans is similar.
Table 1 presents the clinical characteristics of both datasets. The Fre dataset
contains COPD subjects and non-COPD subjects. The non-COPD subjects are referred
from the out-patient clinic to have a HRCT scan due to different respiratory problems.
Aal contains only subjects with COPD.
Table 1. Clinical characteristics of subjects belonging to both datasets. GOLD
stratification reflects the classification of the COPD patients according to the GOLD
combined risk stratification assessment [3].
Dataset Gender Age Smoking GOLD Stratification FEV1 (%) DLCO (%)
(M/F) current former never A B C D
Fre
COPD 7/1 66 [48-77] 1 7 0 1 3 3 1 58 [36-91] 55 [32-90]
non-COPD 3/5 56 [25-73] 1 2 5 96 [63-137] 74 [62-83]
Aal 34/38 66 [32-83] 23 48 1 24 12 18 18 62 [18-111] 55 [15-108]
3.2 Experimental Setup
Two sets of experiments are performed, which differ in the ways that the positive and
negative bags are defined. There are two ways to define the bag labels: by thresholding
the COPD stratification (A-D = positive, otherwise = negative), and by thresholding
the DLCO predicted value (<60% = low (positive), >60% = high (negative)). The
value of 60%, rather than the traditional value of 80% is chosen due to the small sample
of subjects with DLCO >80%. Thus, patients with lower DLCO (which could be
indicative of COPD, but does not define the COPD diagnosis) are included in the high
DLCO class.
To train and evaluate the classifiers, 50 patches with a size of 41× 41× 41 pixels are
randomly extracted from each HRCT scan. Previous studies [19, 29] have demonstrated
that 50 patches is sufficient to classify an entire scan. The patches are selected inside
the lung parenchyma using the lung masks.
In each patch, textural features extracted from co-occurrence matrices and Gaussian
filter banks are computed. A total of 780 features are computed from co-occurrence
matrices, and 320 features are obtained from Gaussian filter banks. High-dimensional
feature representations are chosen because previous studies with MIL classifiers and
similar feature representations [19,22] showed good results in terms of bag-level
performance. We will also briefly discuss our experiences with lower-dimensional
features in the Results section.
3.2.1 Cross-validation
For each set of experiments, a 4-fold stratified cross-validation is performed, such that
each fold contains a similar distribution of subjects. Thus, Fre and Aal datasets are
combined and each fold contains non-COPD and COPD subjects with varying degrees
of COPD severity, as well as subjects with low and high DLCO values.
The 4-fold cross validation uses 3 folds for training and the fourth fold for evaluation.
During training on the 3 folds, an internal 3-fold cross-validation is done to optimize the
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parameters. These parameters, which are selected only using the 3 folds of the training
set, are then used to train a classifier on all the 3 training set folds. The classifier is
evaluated on the fourth fold. This is repeated 4 times, so each of the folds is used once
for evaluation.
MILES-Q and miSVM-Q classifiers are investigated, and the best parameters for
each classifier are selected using the training set. The parameter ranges for both
classifiers are as follows: polynomial kernel p ∈ {1, 2}, radial basis kernel
rbf ∈ {8, 10, 12, 14, 16, 20}, regularization parameter
C ∈ {0.001, 0.003, 0.01, 0.03, 0.1, 0.3, 1}, and quantile parameter
q ∈ {0.25, 0.5, 0.75, 0.9, 1}.
3.3 Evaluation
3.3.1 Classifier evaluation
During the 4-fold cross-validation, the best combination of parameters for each classifier
is extracted on the three training folds. For the test results, the bag AUC (area under
the receiver-operating curve) and Separability (Eq. 1) are examined. The bag AUC
expresses the ability of the classifier to rank a randomly drawn positive HRCT scan
higher than randomly drawn negative HRCT scan (i.e., assign a higher posterior
probability to a positive scan). Therefore, AUC is not sensitive to class imbalance: if a
classifier assigns all cases to the majority class, the accuracy would be high, but the
AUC would be equal to 0.5. The Separability reflects the classifier’s ability to
distinguish patches with signs of COPD and healthy lung tissue, without having access
to such labels. Performance is considered good when the bag AUC is as high as possible
and the Separability is as large as possible.
3.3.2 Clinical validation
In the clinical validation, the set of features and the classifier with the best performance
in terms of bag AUC and Separability on the training sets are chosen for each of the
test folds. The classifier is tested on 10 slices per HRCT scan. This number of slices is
chosen to keep manual annotations by the radiologists feasible. The slices are spaced 25
slices apart in each HRCT scan, avoiding the slices belonging to the top and bottom
parts of the lungs. In selected slices, the classifier classifies every 10th voxel in both
directions in the slice, that is, inside the lung mask for that slice.
Two radiologists, expert 1 and expert 2, with 40 and ten years of experience,
respectively, working with HRCT scans on a daily basis annotated all emphysema
lesions in the same ten slices per scan in which the classifier is tested. The manual
annotations are performed using OsiriX imaging software (www.osirix-viewer.com) using
a medical display (BARCO E-2621). The annotation process is blinded. Thus, the
experts do not know the outlines of the other expert or the classification results. The
amount of emphysema annotated by each expert, in percentage, is computed, as is the
percentage of emphysema on which both experts agreed.
For local emphysema detection, the default threshold of 0.5 is used to transform the
posterior probabilities into emphysema or healthy category labels.
Spearman correlation analysis is performed, in which the emphysema percentages of
the classifier are compared with the manual annotations, results from spirometry and
DLCO, and a simple method based on the threshold of LAA. The threshold is set to
-950 HU, which has been demonstrated to be an acceptable threshold for density based
emphysema quantification [30]. A comparison of correlations from independent samples
using the Fisher r-to-z transformation is computed to assess the significance of the
differences between the results from the Spearman correlation.
7
The inter-observer variability between experts is also investigated using the Dice
similarity coefficient (DSC), which is a measurement of similarity. The values of DSC
range from 0 if there is no agreement to 1 if there is a perfect match.
4 Results
4.1 Classifier performance
As shown in Table 2, miSVM-Q has higher performance than MILES-Q on both bag
AUC and Separability. For miSVM-Q, Gaussian features provide larger Separability and
generally better bag classification than co-occurrence features. The combination of
co-occurrence matrices and Gaussian features does not improve the results obtained
with these features alone. In general, both classifiers can better distinguish obstructions
given by low FEV1 (ClassCOPD) than by low DLCO (ClassDLCO).
Additionally, lower-dimensional feature combinations are briefly investigated, such as
orientation-invariant co-occurrence features (60 features) and using only a histogram of
intensities (10 features); however, the results were worse than those obtained using the
full co-occurrence or Gaussian features.
This suggests that, similar to earlier studies [19,22] the relatively high feature
dimensionality is not detrimental to these classifiers.
Table 2. miSVM-Q and MILES-Q results using COPD (ClassCOPD) and DLCO (ClassDLCO) labels. S: separability
(×100); AUC: bag AUC (×100).
miSVM-Q MILES-Q
DLCO COPD DLCO COPD
Feature AUC S AUC S AUC S AUC S
Cooc 70.9 ± 6.3 4.1 100.0 ± 0.0 44.2 53.0 ± 10.3 0.7 93.8 ± 6.2 17.1
Gauss 81.6 ± 10.2 21.7 100.0 ± 0.0 61.1 69.1 ± 6.6 7.0 89.4 ± 6.4 27.8
Both 59.5 ± 5.4 2.9 95.0 ± 3.5 19.1 50.8 ± 11.3 -0.1 78.8 ± 18.2 17.5
To support the classifier evaluation, we additionally visualize one of the
high-dimensional feature spaces (Gaussian texture features), which consists of patches
from COPD subjects and non-COPD subjects in Fig 2. Note that, due to the MIL
representation, there is no straightforward way to cluster the subjects themselves. This
dimensionality reduction and visualization is performed using t-SNE [31], a popular
method which aims to represent the local structure of the patches in the
high-dimensional space as well as possible, without using the labels of the patches. The
labels are only added to the plot for visualization. Note that the embedding is the same
after rotation, there are therefore no meaningful names that can be assigned to the
dimensions, similar to principal component analysis.
We use all the patches from non-COPD subjects, and a random sample (due to class
imbalance) of patches from the COPD subjects, for an uncluttered visualization. The
visualization shows a large overlapping area with patches that both types of subjects
have. However, on the periphery (bottom left, and the right side of the plot) there are
regions which only contain patches from COPD subjects. A subject having patches in
these areas could therefore be classified as belonging to the COPD class.
4.2 Association with PFTs
Based on the classifier evaluation results, miSVM-Q and Gaussian features are selected
for the clinical validation. The parameters of miSVM-Q for the different test folds are
selected during cross-validation as before.
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Figure 2. 2D visualization of patches from COPD and non-COPD subjects using the
Gaussian feature representation. The patches have different distributions, which helps
the MIL classifier to classify a subject correctly.
Table 3 presents the percentage of emphysema detected by the different methods
and their correlation with DLCO and FEV1. The correlations are considered significant
at the 0.05 level. Moreover, analysis using the Fisher r-to-z transformation is computed
which shows that there is not a significant difference between the correlation coefficients
from the Spearman analysis.
Table 3. Spearman correlation results with data from pulmonary tests. ClassCOPD:
results from classifier with COPD label; ClassDLCO: results from classifier with DLCO
label; Thr LAA: Threshold scan based on low attenuation areas; Agree Exp: area of
agreement between the manual annotations of both experts; rho: correlation coefficient.
ClassCOPD ClassDLCO Thr LAA Agree Exp Expert1 Expert2
DLCO val
rho -0.477 -0.571 -0.513 -0.478 -0.472 -0.596
p Value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <.0001
FEV1
rho -0.283 -0.383 -0.461 -0.298 -0.316 -0.314
p Value 0.016 <0.0001 <0.0001 0.011 0.007 0.007
4.3 Association with manual annotations
The agreements of the annotations between the two radiologists and between the
classifier and the radiologists are investigated. The corresponding scatter plots between
the percentage of emphysema calculated by the classifiers and the average percentage of
emphysema annotated by the two radiologists are shown in Fig 3. 3.
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Furthermore, Spearman correlation analysis are calculated between the percentage of
emphysema computed from the manual annotations of the two experts (rho=0.756,
p = 1.71e− 14), and the percentage of emphysema computed from the classifiers and
the average percentage of emphysema from the manual annotations (ClassDLCO:
rho=0.561, p = 3.01e− 7; ClassCOPD: rho=0.515, p = 4e− 6).
An example of the results from the classifiers, the manual annotations from the
experts, and the threshold using LAA is presented in Fig 4.
Although at instance level, the agreement between the classifier and the experts is
not perfect, the emphysema quantification is consistent when using ClassDLCO. In
contrast to ClassCOPD, ClassDLCO identifies small emphysema areas in the same
patients in which the experts do not make annotations or the annotations are small, and
it identifies larger emphysema areas where experts annotate large emphysema lesions.
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Figure 3. Percentage of emphysema (log scale for visibility) per subject annotated by
the experts and computed by the classifiers.
The agreement between the annotations from both experts is also calculated using
DSC which results in a value of 0.34, indicating a weak agreement between experts.
5 Discussion
5.1 Classifier performance
In contrast with previous studies, this study uses an MIL approach to automatically
identify emphysema regions in COPD patients without requiring manually annotated
HRCT scans for training. Two robust versions of the MILES and miSVM classifiers are
presented. Because good bag-level (patient classification) performance does not
correspond to good instance-level (patch classification) performance and vice
versa [32–34], both bag-level AUC and a measure of instance-level performance, called
Separability, are taken into account. The best performing classifier is miSVM-Q. Other
studies [19,21] have shown that instance-level classifiers, such as miSVM, tend to have
lower bag-level performance. In the present study, the bag-level performance of
miSVM-Q is improved compared to the original miSVM by relaxing the condition that
a bag should be classified as positive as soon as a single positive instance is detected.
The performance achieved at the bag-level is very high, with an AUC equal to 100%
for the COPD class label. This result could be explained by the fact that half of the
subjects in both datasets are in the severe and very severe stage of the GOLD
stratification and, therefore, these stages are easier to identify by the classifier. In
[19,22] the same type of labels were used, however an AUC close to 75% was achieved.
However, the dataset used was from a screening trial, and thus contained a much higher
fraction of mild COPD subjects, which were difficult to classify correctly.
We used several parameters which were determined in previous studies, such as the
patch size of 41x41x41 and using 50 patches to represent an entire scan. The results in
the current study demonstrate that for these data, these are also reasonable choices.
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However, this would in general depend on a number of factors. For example, we would
expect that if the cases in the dataset are all mild, a larger number of patches would be
needed to capture some areas with emphysematous tissue. Another factor is the image
resolution and therefore the physical size of the patch - for a smaller physical size, we
expect that more patches would be needed. There are limits to this trade-off, as a much
smaller physical size would not be able to capture the appearance of emphysema.
Earlier studies [19,22] did not investigate the agreement of the classifier with manual
instance-level annotations. Therefore, when making choices such as patch size, number
of patches per scan, and so forth, the instance-level performance was not considered.
Consequently, it would be worth investigating how the patch size and number of patches
(which in this study are set to the same values as in [19,22]) would affect the
instance-level performance.
Features derived from Gaussian filters, using both classifiers and both labels, provide
larger Separability than co-occurence features or their combinations. All of these feature
sets are high-dimensional compared to the size of the data. However, we observed that
using lower-dimensional versions of these features reduced the performance, and
high-dimensional features have been used with success in previous studies [19,22].
These observations are consistent with studies of MIL classifiers on non-medical
datasets, such as [35], where for example the Web datasets have 2K instances in 5K
dimensions, but where miSVM is the second best classifier, and the best classifier that
can provide instance-labels. The miSVM classifier is therefore effective at dealing with
high dimensional data, by using regularization to reduce overfitting.
An interesting difference with respect to the relative dimensions is between the
miSVM-Q and MILES-Q. Because miSVM-Q is an instance-level approach, its effective
sample size is the total number of patches used, while the effective sample size of MILES
is lower, i.e. the total number of subjects. This could explain why the performances of
miSVM-Q are higher overall. This is also consistent with previous results on similar
COPD data [19] and non-medical datasets [35]. Therefore, MILES appears to be more
prone to overfitting. It would be of interest to investigate how increasing the number of
patches per scan would affect the results - for miSVM this would mean an increased
sample size, but for MILES it would mean an increased dimensionality.
We did not investigate the use of deep learning methods. This could be done in
three ways: training a network from scratch, fine-tuning a pretrained network or using
“off-the-shelf” features. Based on recent results in medical imaging [36], we expect that
training from scratch would not lead to good results due to the small dataset. We
expect fine-tuning and “off-the-shelf” method (which could be used together with the
miSVM-Q or MILES classifiers) to be more successful than training from scratch.
However, both methods would depend on the data that is used to pretrain the networks,
as well as several other parameters. Combining traditional features with features
extracted by deep learning has also shown to be effective [37], and would be interesting
direction for future work.
5.2 Clinical validation
Spirometry has been widely used as an indicator of COPD severity due to the
correlation between FEV1/FVC and airway obstruction. However, FEV1 does not
reflect structural changes in the lung parenchyma, and therefore, it is not a reliable
indicator of emphysema lesions. In contrast, DLCO is a good indicator of the level of
anatomic emphysema. In this study, a Spearman correlation analysis between the best
classifier from the classifier evaluation, miSVM-Q, and the PFTs is computed. The
results in the present study show, as presented in Table 3, that the classifier using both
labels has a higher correlation with DLCO values than with FEV1. This result is
comparable to the result in [38], where the emphysema segmentation using a
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texture-based approach had a better correlation with DLCO than with values from
FEV1. This is explained because FEV1 measures airflow obstruction; however, this is
only partially reflected in emphysema lesions. The classifier that is trained on the
COPD label based on FEV1 values, likely detects mostly signs of emphysema and
therefore, still correlates better with DLCO than with FEV1.
The correlations from the classifier with the PFTs are also compared with the
correlations between the PFTs and a density mask method that has been widely used to
quantify emphysema lesions in CT scans. The results show that the density based
method correlates moderately better with FEV1 than both the classifiers and the expert
evaluations, and the same behaviour can be observed in [38]. This may be explained by
the inability of the density mask to discriminate between air trapping and emphysema
due to the nature of their thresholds [39]. However, other studies from the literature
that aim to quantify emphysema [16,22] show a better correlation between FEV1 with
their proposed texture analysis methods than a traditional density based method.
This study uses the PFTs as the most reliable measurement to validate the results of
the classifier despite manual annotations by two independent experts being available.
This is due to the weak agreement between experts in the annotations of emphysema, as
shown by the Spearman correlation results in Section 4.3 and the Dice similarity
coefficient. This is in agreement with [40], who showed a low inter-observer agreement
in a task of quantifying emphysema in whole lungs. As shown in Fig 3, ClassCOPD
overestimates the amount of emphysema in comparison with the manual annotations.
This result can be produced by the small dataset of non-COPD. However, ClassDLCO
generally tends to agree with experts on the size of emphysema areas. The scatter plots
show that ClassDLCO has a good agreement with the experts’ annotations in severe
and very severe cases, but the agreement is fair in moderate patients and poor in mild
patients. ClassDLCO overestimates the emphysema in these cases.
However, these findings in conjunction with the improved correlation with DLCO
compared to manual annotations could indicate that ClassDLCO is more sensitive to
early changes in the lung parenchyma and can detect emphysema even before these
changes are able to be detected visually. To confirm this result, future studies should
investigate the progression of emphysema in the areas where the classifier finds
emphysema, but that were not assessed visually. This will also help to reduce
inter-observer variability, which is a major limitation in visual assessment, as other
studies have reported [4, 41]. Furthermore, the correlation results between the
ClassDLCO and DLCO values show that quantitative assessment of emphysema with
the presented method provides an important measurement of the reduction in the
alveolar area. In addition, as suggested in [42], a better detection of emphysema in
HRCT scans can also be used in refining the prediction of the 6 minute walking distance
test.
5.3 Limitations
A limitation of this study is the size and balance of the datasets. The Fre dataset is
very small, and the Aal dataset does not contain any controls. Due to this imbalance,
the DLCO threshold used is lowered to 60%; thus, patients with lower DLCO values are
included in the high DLCO class (which could be seen as healthy, although note that
the COPD diagnosis is based on spirometry). The texture features extracted from the
non-COPD group could have a similar representation as the features extracted from
COPD patients because different lung diseases could appear in CT scans as LAA as
emphysema does, i.e. cystic lung disease. Therefore, it would be desirable to include
scans without any pathology.
A related problem is the fact that the Fre and Aal datasets have different acquisition
parameters, which can negatively affect classification performance [43]. An improvement
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in performance will be expected if the appearance of healthy tissue could be learned
from both datasets rather than only Fre. An alternative would be to use techniques
such as intensity normalization or transfer learning classifiers to reduce the differences
between datasets.
6 Conclusion
This study presented two new versions of multiple instance classifiers which identify
emphysema regions in patients suffering from COPD without requiring manual
annotations. On a clinical dataset with 88 subjects in total, the proposed method
showed a good correlation with the pulmonary function tests, particularly with DLCO.
The proposed method had a moderate correlation with manual annotations of
emphysema, however, this correlation was higher than that of a density based method,
which was also moderately correlated with manual annotations. Therefore it could be
considered as a reliable tool to support radiologists in the assessment of emphysema to
reduce the inter- and intra-observer variability. As future work, validating the results on
a larger and more balanced dataset, and investigating the effect of different acquisition
parameters, are recommended.
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Figure 4. Example of results in randomly selected slices for the density based method,
manual annotations from the experts, and classifier results using miSVM-Q and
Gaussian features. From left to right: patients with mild, moderate, severe and very
severe COPD.
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